{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:07:34Z","timestamp":1776107254069,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.07647.BD"],"award-info":[{"award-number":["2021.07647.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MS-SECTICS-Decit\/CNPq","award":["DTI-A MS-SECTICS-Decit\/CNPq n\u00b0 16\/2023"],"award-info":[{"award-number":["DTI-A MS-SECTICS-Decit\/CNPq n\u00b0 16\/2023"]}]},{"name":"Funda\u00e7\u00e3o Rui Os\u00f3rio de Castro"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Productivity fellowship"],"award-info":[{"award-number":["Productivity fellowship"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01645-y","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:17:13Z","timestamp":1745389033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High B7-H3 protein expression in Medulloblastoma is associated with metastasis and unfavorable patient outcomes"],"prefix":"10.1186","volume":"20","author":[{"given":"Patr\u00edcia","family":"Font\u00e3o","sequence":"first","affiliation":[]},{"given":"Gustavo Ramos","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Daniel Antunes","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Rui Ferreira","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Norberto","family":"Stavale","sequence":"additional","affiliation":[]},{"given":"Suzana Maria Fleury","family":"Malheiros","sequence":"additional","affiliation":[]},{"given":"Carlos Almeida","family":"J\u00fanior","sequence":"additional","affiliation":[]},{"given":"Bruna Minniti","family":"Man\u00e7ano","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"1","key":"1645_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma Nat reviews Disease primers. 2019;5(1):11.","journal-title":"Medulloblastoma Nat reviews Disease primers"},{"issue":"8","key":"1645_CR2","first-page":"1231","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neurooncology. 2021;23(8):1231\u201351.","journal-title":"Neurooncology"},{"key":"1645_CR3","doi-asserted-by":"crossref","unstructured":"Cotter JA, Hawkins C, Medulloblastoma. WHO 2021 and Beyond. Pediatric and developmental pathology: the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2022;25(1):23\u201333.","DOI":"10.1177\/10935266211018931"},{"issue":"4","key":"1645_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","volume":"123","author":"M Kool","year":"2012","unstructured":"Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012;123(4):473\u201384.","journal-title":"Acta Neuropathol"},{"key":"1645_CR5","doi-asserted-by":"crossref","unstructured":"Barateiro L, de Oliveira Cavagna R, Dos Reis MB, de Paula FE, Teixeira GR, Moreno DA et al. Somatic mutational profiling and clinical impact of driver genes in Latin-Iberian medulloblastomas: Towards precision medicine. Neuropathology: official J Japanese Soc Neuropathology. 2024.","DOI":"10.1111\/neup.12979"},{"key":"1645_CR6","doi-asserted-by":"crossref","unstructured":"Martirosian V, Neman J, Medulloblastoma. Challenges and advances in treatment and research. Cancer Rep. 2018;2.","DOI":"10.1002\/cnr2.1146"},{"issue":"1","key":"1645_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Signal Transduct Target therapy. 2023;8(1):320.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"1645_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-023-00372-8","volume":"12","author":"W Ma","year":"2023","unstructured":"Ma W, Xue R, Zhu Z, Farrukh H, Song W, Li T, et al. Increasing cure rates of solid tumors by immune checkpoint inhibitors. Experimental Hematol Oncol. 2023;12(1):10.","journal-title":"Experimental Hematol Oncol"},{"key":"1645_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers13215387","volume":"13","author":"MJ Voskamp","year":"2021","unstructured":"Voskamp MJ, Li S, van Daalen KR, Crnko S, Ten Broeke T, Bovenschen N. Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives. Cancers. 2021;13:21.","journal-title":"Cancers"},{"key":"1645_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/ITT.S198162","volume":"9","author":"TF Kabir","year":"2020","unstructured":"Kabir TF, Kunos CA, Villano JL, Chauhan A. Immunotherapy for Medulloblastoma: Current Perspectives. ImmunoTargets therapy. 2020;9:57\u201377.","journal-title":"ImmunoTargets therapy"},{"key":"1645_CR11","doi-asserted-by":"publisher","first-page":"1062856","DOI":"10.3389\/fimmu.2023.1062856","volume":"14","author":"RF Marques","year":"2023","unstructured":"Marques RF, Moreno DA, da Silva L, Leal LF, de Paula FE, Santana I, et al. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Front Immunol. 2023;14:1062856.","journal-title":"Front Immunol"},{"issue":"1","key":"1645_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","volume":"15","author":"B Zhao","year":"2022","unstructured":"Zhao B, Li H, Xia Y, Wang Y, Wang Y, Shi Y, et al. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. J Hematol Oncol. 2022;15(1):153.","journal-title":"J Hematol Oncol"},{"key":"1645_CR13","doi-asserted-by":"crossref","unstructured":"Koumprentziotis IA, Theocharopoulos C, Foteinou D, Angeli E, Anastasopoulou A, Gogas H et al. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3. Vaccines. 2024;12(1).","DOI":"10.3390\/vaccines12010054"},{"issue":"5","key":"1645_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/2767-9764.CRC-23-0546","volume":"4","author":"CD Miller","year":"2024","unstructured":"Miller CD, Lozada JR, Zorko NA, Elliott A, Makovec A, Radovich M, et al. Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer Res Commun. 2024;4(5):1369\u201379.","journal-title":"Cancer Res Commun"},{"key":"1645_CR15","doi-asserted-by":"crossref","unstructured":"Liu L, Yao Z, Liu Y, Li Y, Ding Y, Hu J et al. A Pan-Cancer Analysis of the Oncogenic Role of CD276 in Human Tumors. Genes. 2024;15(12).","DOI":"10.3390\/genes15121527"},{"issue":"2","key":"1645_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tranon.2019.11.006","volume":"13","author":"UB Maachani","year":"2020","unstructured":"Maachani UB, Tosi U, Pisapia DJ, Mukherjee S, Marnell CS, Voronina J, et al. B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors. Translational Oncol. 2020;13(2):365\u201371.","journal-title":"Translational Oncol"},{"issue":"3","key":"1645_CR17","first-page":"458","volume":"26","author":"S Coy","year":"2024","unstructured":"Coy S, Lee JS, Chan SJ, Woo T, Jones J, Alexandrescu S, et al. Systematic characterization of antibody-drug conjugate targets in central nervous system tumors. Neurooncology. 2024;26(3):458\u201372.","journal-title":"Neurooncology"},{"key":"1645_CR18","doi-asserted-by":"publisher","first-page":"1237170","DOI":"10.3389\/fonc.2023.1237170","volume":"13","author":"DA Moreno","year":"2023","unstructured":"Moreno DA, Bonatelli M, Antoniazzi AP, de Paula FE, Leal LF, Garcia FAO, et al. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Front Oncol. 2023;13:1237170.","journal-title":"Front Oncol"},{"issue":"5","key":"1645_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41591-020-0821-8","volume":"26","author":"J Theruvath","year":"2020","unstructured":"Theruvath J, Sotillo E, Mount CW, Graef CM, Delaidelli A, Heitzeneder S, et al. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid\/rhabdoid tumors. Nat Med. 2020;26(5):712\u20139.","journal-title":"Nat Med"},{"issue":"8","key":"1645_CR20","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, et al. CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clin cancer research: official J Am Association Cancer Res. 2019;25(8):2560\u201374.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"key":"1645_CR21","doi-asserted-by":"crossref","unstructured":"Li S, Poolen GC, van Vliet LC, Schipper JG, Broekhuizen R, Monnikhof M et al. Pediatric medulloblastoma express immune checkpoint B7-H3. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2022;24(6):1204\u20138.","DOI":"10.1007\/s12094-021-02762-y"},{"issue":"1","key":"1645_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2559.2008.03070.x","volume":"53","author":"A Gregorio","year":"2008","unstructured":"Gregorio A, Corrias MV, Castriconi R, Dondero A, Mosconi M, Gambini C, et al. Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. Histopathology. 2008;53(1):73\u201380.","journal-title":"Histopathology"},{"issue":"4","key":"1645_CR23","first-page":"732","volume":"30","author":"RK Kanchan","year":"2020","unstructured":"Kanchan RK, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel DL, et al. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3). Brain pathology (Zurich. Switzerland). 2020;30(4):732\u201345.","journal-title":"Switzerland)"},{"issue":"5","key":"1645_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/neup.12508","volume":"38","author":"LF Leal","year":"2018","unstructured":"Leal LF, Evangelista AF, de Paula FE, Caravina Almeida G, Carloni AC, Saggioro F, et al. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology: official J Japanese Soc Neuropathology. 2018;38(5):475\u201383.","journal-title":"Neuropathology: official J Japanese Soc Neuropathology"},{"issue":"1","key":"1645_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-022-03965-1","volume":"157","author":"DA Moreno","year":"2022","unstructured":"Moreno DA, da Silva LS, Zanon MF, Bonatelli M, de Paula FE, de Medeiros Matsushita M, et al. Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study. J Neurooncol. 2022;157(1):27\u201335.","journal-title":"J Neurooncol"},{"issue":"4","key":"1645_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-011-0899-7","volume":"123","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 2012;123(4):615\u201326.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1645_CR27","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/ijc.27566","volume":"131","author":"VA Ingebrigtsen","year":"2012","unstructured":"Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer. Int J Cancer. 2012;131(11):2528\u201336.","journal-title":"Int J Cancer"},{"issue":"2","key":"1645_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","volume":"53","author":"Y Sun","year":"2006","unstructured":"Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung cancer (Amsterdam Netherlands). 2006;53(2):143\u201351.","journal-title":"Lung cancer (Amsterdam Netherlands)"},{"key":"1645_CR29","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/j.wneu.2019.10.044","volume":"135","author":"J Deng","year":"2020","unstructured":"Deng J, Ma M, Wang D, Zhu H, Hua L, Sun S, et al. Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma. World Neurosurg. 2020;135:e12\u20138.","journal-title":"World Neurosurg"},{"key":"1645_CR30","doi-asserted-by":"crossref","unstructured":"Joshi V, Beecher K, Lim M, Stacey A, Feng Y, Jat PS et al. B7-H3 Expression in Breast Cancer and Brain Metastasis. Int J Mol Sci. 2024;25(7).","DOI":"10.3390\/ijms25073976"},{"key":"1645_CR31","doi-asserted-by":"crossref","unstructured":"Purvis IJ, Velpula KK, Guda MR, Nguyen D, Tsung AJ, Asuthkar S. B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role. Int J Mol Sci. 2020;21(19).","DOI":"10.3390\/ijms21197050"},{"key":"1645_CR32","doi-asserted-by":"crossref","unstructured":"Purvis IJ, Avilala J, Guda MR, Venkataraman S, Vibhakar R, Tsung AJ et al. Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. J Clin Med. 2019;8(8).","DOI":"10.3390\/jcm8081158"},{"key":"1645_CR33","doi-asserted-by":"crossref","unstructured":"Shishido K, Purvis IJ, Velpula KK, Venkataraman S, Vibhakar R, Asuthkar S. Targeting B7\u2013H3 through EZH2 inhibition in MYC\u2013positive Group 3 medulloblastoma. Oncol Rep. 2023;49(6).","DOI":"10.3892\/or.2023.8556"},{"issue":"1","key":"1645_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.36401\/JIPO-23-18","volume":"7","author":"K Feustel","year":"2024","unstructured":"Feustel K, Martin J, Falchook GS. B7-H3 Inhibitors in Oncology Clinical Trials: A Review. J immunotherapy precision Oncol. 2024;7(1):53\u201366.","journal-title":"J immunotherapy precision Oncol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01645-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:17:27Z","timestamp":1745389047000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01645-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1645"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01645-y","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee in Research from Barretos\u2019 Cancer Hospital (Project #1248\/2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}